The previous study demonstrated TIMM50 could promote tumor proliferation and invasion in NSCLC by enhancing the phosphorylation of its downstream ERK/P90RSK signaling pathway [46]; TIMM50 facilitated proliferation, migration and chemoresistance in breast cancer cells [47, 48]. Here, RPS6KA1 is linked to breast carcinoma.